Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Sep 22, 2020

Oxford Nanopore Technologies Licenses Genetics Research's CRISPR DNA Enrichment Technology

Under the non-exclusive deal, Oxford Nanopore can include the technology, which targets long DNA fragments, in its nanopore sequencing products.

Sep 02, 2020

UK Invests $667M to Expand SARS-CoV-2 Testing Capacity

The funding will be used to start a new trial to assess the benefits of repeat population testing, expand existing trials, and increase PCR-based testing capacity.

Aug 14, 2020

In Brief This Week: BGI, Illumina, Pacific Biosciences, Oxford Nanopore, Co-Diagnostics, More

News items for the week of August 10, 2020.

Aug 11, 2020

Numbers Needed

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

Aug 03, 2020

Fast COVID-19 Testing for UK

The UK is implementing COVID-19 testing with a 90-minute turnaround time.

Aug 03, 2020

NHS Will Roll Out COVID-19 Tests From DnaNudge, Oxford Nanopore Across UK

Both tests can detect SARS-CoV-2 in 90 minutes and will detect viruses like influenza and respiratory syncytial virus that tend to occur in the winter.

Jul 09, 2020

Dual-Reader Nanopore Promises Improved Homopolymer Sequencing Accuracy

Premium

The new pore, a complex between E. coli CsgG and part of CsgF, called certain homopolymers more accurately than an engineered version of CsgG.

Jun 26, 2020

New Products Posted to GenomeWeb: Oxford Nanopore, Guardant Health, IDT, More

May 28, 2020

Oxford Nanopore Technologies Raises £48.4M in Private Financing

The company is also working on a diagnostic COVID-19 test, called LamPore, that will run on its MinIon and GridIon nanopore sequencing platforms

Apr 22, 2020

New Zealand Funds Research Pairing Ubiquitome, Oxford Nanopore Devices for SARS-CoV-2 Detection

Combining Ubiquitome's handheld PCR device and Oxford Nanopore's sequencer may enable a single person to screen 500 samples and obtain 24 whole genome sequences per day.

Pages

The Scan

Another Protocol Released

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

From Just Some Blood

Time magazine looks into how liquid biopsies are changing cancer care.

Numerous Countries Agree to Vaccine Plan

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

PNAS Papers on Hypertrophic Cardiomyopathy, Major Depression, Spanish SARS-CoV-2 Cat

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.

What's Popular?

In Oxford Nanopore

  1. Oxford Nanopore Technologies Licenses Genetics Research's CRISPR DNA Enrichment Technology

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.